Skip to content

Evaluation of Drainable Volume Measurements During VA-ELS

Evaluation of Drainable Volume Measurements and Their Usage for Predicting Optimal Cardiac Support in Patients Supported by Veno-arterial Extracorporeal Life Support

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02326506
Enrollment
10
Registered
2014-12-29
Start date
2014-09-30
Completion date
Unknown
Last updated
2016-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Arrest

Keywords

Extracorporeal Membrane Oxygenation, Cardiopulmonary Bypass

Brief summary

Veno-arterial extracorporeal life support (VA-ELS) is used to support patients with acute cardiac failure. In that context, sufficient drainable venous volume is crucial for reliable and adequate support. To date, no reliable measurement method exists to monitor drainable volume adequately. Furthermore, it is still unresolved how to diagnose adequate cardiac recovery. Previous (pre)clinical studies showed that the calculation of the dynamic filling index may provide a valuable parameter to monitor the drainable volume in patients supported by VAELS. In addition, a case report showed that measurement of the dynamic filling index could successfully be used to estimate cardiac recovery in a single patient supported by VA-ELS in the ICU. This study will assess the dynamic filling index as a representation for drainable volume and cardiac recovery using standard recorded perfusion data in patients supported by VA-ELS

Interventions

DEVICEVA-ELS pump speed variations

Small variations in the pump speed of the veno-arterial extracorporeal life support (VA-ELS) pump

Sponsors

Maastricht University Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Written informed consent of the relative(s) or legal representative(s) * Supported by VA-ELS at the ICU * \>18 years

Exclusion criteria

\- Pregnancy

Design outcomes

Primary

MeasureTime frame
TEE resultsparticipants will be followed for the duration of the VA-ELS support, an expected average of 1 week

Countries

Netherlands

Contacts

Primary ContactMartine E. Bol, MSc.
m.bol@maastrichtuniversity.nl

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026